Pharmaceutical Benefits Scheme (PBS)

The official online source for information on your PBS.

This web site contains information on the Pharmaceutical Benefits Scheme including details of the medicines subsidised by the Australian Government as well as information for consumers, carers, health professionals and the pharmaceutical industry. The PBS is part of Australia's broader National Medicines Policy (NMP).

 

PBS News Updates

Subscribe to receive email notification of PBS news updates.

 

Post-market Review of Authority Required PBS Listings Public Consultation

13 August 2014

Public consultation on the Authority Required PBS medicines is now open and interested stakeholders can provide comments about any of the Authority Required medicines under consideration in the form of a submission. Submissions will be accepted from Wednesday, 13 August 2014 until 5pm Wednesday, 8 October 2014. Information on how to make comments through a submission can be found on the Public Consultation on Authority Required Medicines web page.

 

Submissions open for the Life Saving Drugs Programme Post-market Review

11 August 2014

The public submission process for the Post-market Review of the Life Saving Drugs Programme (LSDP review) is now open. 

Interested organisations and individuals are invited to provide a submission addressing the Review’s Terms of Reference. To make a submission please go to the Public Consultation page.

Due to the expected public interest in the LSDP Review the public submission process on the Terms of Reference will be open for three months and will close at 5pm Monday, 10 November 2014.

Further information on the Review is available on the LSDP Review webpage.

 

Pharmaceutical Benefits Scheme listing of ivacaftor (Kalydeco) for cystic fibrosis 

11 August 2014

A stakeholder meeting was held on 31 July 2014 to discuss the Pharmaceutical Benefits Scheme (PBS) listing of ivacaftor (Kalydeco) for the treatment of cystic fibrosis in patients aged six years and older who have a G551D mutation in the CFTR (cystic fibrosis transmembrane conductance regulator) gene.

The meeting’s outcome statement reflects the pay for performance framework recommended by the Pharmaceutical Benefits Advisory Committee (PBAC) in March 2014, under which all eligible patients could be treated with PBS-subsidised ivacaftor but the price paid by the Government varies depending on the magnitude of the benefit gained by patients, in recognition that not all patients respond equally to treatment.  Should the pay for performance framework not be successfully negotiated with the sponsor of the medicine, the criteria for response could be used as stopping rules in a manner similar to many other PBS listings.

A detailed outcome statement is available on the news page.

 

PBS Website Update - 1 August 2014

1 August 2014

The Schedule of Pharmaceutical Benefits was updated on 1 August 2014 and the Summary of Changes can be found on the New, Amended and Deleted Items page.

The following updates have also been made to the PBS Website:

 

PBS Hospital Medication Chart

28 July 2014

The Australian Commission on Safety and Quality in Health Care (ACSQHC, the Commission) is developing a national standardised medication chart for PBS use in inpatient and outpatient settings in both public and private hospitals.

The PBS Hospital Medication Chart Project aims to improve the safety of medication management in Australian hospitals through standardised medication charting and medication management practice.  It also helps to reduce the adminstrative burden on hospitals by providing an alternate for prescribers to PBS Prescription Forms in these settings.

 Further information is available on the news page.

 

Indicative 1 October 2014 prices - Price Disclosure (SPD)

18 July 2014

Indicative 1 October 2014 prices resulting from the 2014 October Cycle of Price Disclosure have now been published on the Price Disclosure (SPD) page.

 

PBAC Public Summary Documents

18 July 2014

Additional Public Summary Documents from the March 2014 Pharmaceutical Benefits Advisory Committee (PBAC) meeting are now available.

 

Updated Price Disclosure Guidelines (July 2014) are available

15 July 2014

Updated Price Disclosure Arrangements Procedural and Operational Guidelines are available on the Price Disclosure (SPD) web page.  A Cycles Table, showing relevant dates for first price disclosure cycles based on the month that a drug/MoA becomes subject to price disclosure, is also available on the same web page.

 

Post-Market Review of Products Used for Diabetes Management

4 July 2014

The draft Report from Stage 2 of the Review focussing on Insulin Pumps has now been published and is open for comment. Comments will be accepted until 9am, Monday 21 July 2014. More information about the Review is available on the Diabetes Review page.

 

PBAC Public Summary Documents

4 July 2014

The Public Summary Documents from the March 2014 Pharmaceutical Benefits Advisory Committee (PBAC) meeting are now available.

 

Access to Medicines Working Group Communique - 16 June 2014

1 July 2014

The AMWG Communique for the 16 June 2014 meeting is now available.

 

PBS Website Update - 1 July 2014

1 July 2014

The Schedule of Pharmaceutical Benefits was updated on 1 July 2014 and the Summary of Changes can be found on the New, Amended and Deleted Items page.

The following updates have also been made to the PBS Website:

 

 

2014 October Cycle Outcomes Summary

19 June 2014

The summary of price reductions for the 2014 October Cycle (First SPD) has now been published on the ‘Price Disclosure (SPD)’ page.

 

 

 

Simplified Price Disclosure

6 June 2014

The Simplified Price Disclosure page has been updated. The page now includes an explanation of the steps for the price disclosure calculation method, and a worked sample. It also includes updates to two previous documents that explain the Simplified Price Disclosure amendments to the price disclosure arrangements.

 

 

PBS Website Update - 1 June 2014

1 June 2014

The Schedule of Pharmaceutical Benefits was updated on 1 June 2014 and the Summary of Changes can be found on the New, Amended and Deleted Items page.

The following updates have also been made to the PBS Website:

 

Post-market Review of Authority Required PBS Listings – Public Consultation

27 May 2014

The Terms of Reference for the Post-market Review of Authority Required PBS Listings are now published on the PBS website. Interested stakeholders can provide comments about the terms of reference in the form of a submission. Any submissions will be accepted from 27 May 2014 until 9.00am Monday 16 June 2014. Information on how to make comments through a submission can be found on the Post-market Review of Authority Required PBS Listings Public Consultation web page.

 

Post-market Review of Authority Required PBS Listings

23 May 2014

Under the Australian Government’s National Medicines Policy framework, the Department of Health is conducting a Post-market Review of Authority Required PBS Listings. The objective of the Review is to improve patient safety and care by reducing red tape and administrative burden for health professionals.

Further information regarding the Post-market Review of Authority Required PBS Listings is available on the Reviews page.

 

2014 Budget information on the Pharmaceutical Benefits Scheme

13 May 2014

The 2014 Budget information on the Pharmaceutical Benefits Scheme is available on the Department of Health website.

Further information is also available in the following information sheet.

 

Post-market Review of PBS Medicines Used to Treat Asthma in Children Review

12 May 2014

The draft Report of the PBS Medicines Used to Treat Asthma in Children Review has now been published and is open for comment until 26 May 2014.  More information about the Review is available on the Asthma Review web page.

 

Diabetes Review Stakeholder Forum summaries & upcoming consultation

9 May 2014

The Stakeholder Forums for Stages 2 and 3 of the Post-Market Review of Products used in the Management of Diabetes were held on 12 September 2013. Forum summaries for Stage 2 (insulin pumps) and Stage 3 (type 2 diabetes medicines) are now available. For further information, please refer to the Diabetes Review web page.

Upcoming is the public consultation on the Draft Report for Diabetes Review: Stage 2 (Insulin Pumps) and the Draft Report for Asthma Inhalers in Children. A news item will be sent through the PBS subscription service notifying stakeholders of the open consultation period.
 

Errata to the PBS Schedule for 1 May 2014

8 May 2014

The clinical criterion in the May 2014 PBS Schedule contains a misprint in items 10083Q and 10084R.

The criterion erroneously states:

“Patient must be undergoing chemotherapy plus G-CSF mobilisation and their peripheral blood CD34+ count is less than 10,000 per microlitre on the day of planned collection”

The criterion should read:

“Patient must be undergoing chemotherapy plus G-CSF mobilisation and their peripheral blood CD34+ count is less than 10,000 per millilitre or less than 10 million per litre on the day of planned collection”

The correct wording will appear in the June PBS Schedule.

 

Stakeholder Forum Outcomes: Asthma Post-market Review

6 May 2014

A Stakeholder Forum for the Post-market Review of PBS Medicines Used to Treat Asthma in Children was held in Canberra on 18 November 2013. Attendees included pharmaceutical sponsors of asthma medicines, peak bodies, and individuals (clinicians and consumers).  A summary of outcomes and discussion is available on the Review web page.

 

PBS Website Update – 1 May 2014 

1 May 2014

The Schedule of Pharmaceutical Benefits was updated on 1 May 2014 and the Summary of Changes can be found on the New, Amended and Deleted Items page.

The following updates have also been made to the PBS Website:

 

Australian Statistics on Medicines 2011

17 April 2014

The Australian Statistics on Medicines 2011 is now available.

 

Summary of 1 August 2014 price reductions for the 2014 Supplementary Cycle A by drug / manner of administration / percentage reduction

17 April 2014

The summary of 1 August 2014 price reductions for the 2014 Supplementary Cycle A has now been published on the ‘Price Disclosure (EAPD)’ page of this web site.

 

Tropical Cyclone Ita

11 April 2014

The Department of Health has introduced temporary arrangements to assist residents and pharmacists in areas in Far North Queensland being impacted by Tropical Cyclone Ita.  The information page includes details on how pharmacists can manage additional supplies for residents whose medicine and prescriptions have been lost in the current emergency. Please use the contact numbers in the information page for further information about medicine issues. 

 

PBS Website Update – 1 April 2014

1 April 2014

The Schedule of Pharmaceutical Benefits was updated on 1 April 2014 and the Summary of Changes can be found on the New, Amended and Deleted Items page.

The following updates have also been made to the PBS Website:

 

Confirmation of 1 April 2014 Price Disclosure Prices and New Price Disclosure Fact Sheet

12 March 2014

Confirmation of 1 April 2014 new prices resulting from 2014 Main Cycle of EAPD have now been published in the EAPD section of this website.

A new Price Disclosure Fact Sheet: Differences between IMS Profits Data and Disclosed Data has been published to improve responsible persons' understanding of differences between price disclosure outcomes and any outcomes that may be estimated using IMS data.

 

Streamlined PBS pricing processes to improve access to medicines

7 March 2014

From 1 April 2014, the Government will implement a new streamlined process to reduce the time taken to list medicines on the Pharmaceutical Benefits Scheme (PBS) and improve access to medicines.  A key component of this measure will be the cessation of the operations of the Pharmaceutical Benefits Pricing Authority (PBPA).

The measure will further streamline PBS listing processes by allowing agreement on price to be reached in shorter timeframes following a positive recommendation from the Pharmaceutical Benefits Advisory Committee (PBAC).

As currently, the final decision on the price of a medicine will be made by the Minister (or delegate).  However the streamlined process will allow important new medicines to be listed on the PBS at least four weeks earlier than is presently possible.  At the same time, sponsors will benefit from having additional time, to the end of week five after the meeting of the PBAC, in which to finalise pricing submissions following a positive PBAC recommendation.

Arrangements following cessation of the PBPA will require sponsors of submissions to the PBAC to provide cost of goods information at the time of making the submission but there will be a transition period for these arrangements to assist industry.  There will be no change to the current application processes for sponsors seeking price increases for currently subsidised medicines. 

The PBS website will be updated to reflect the new arrangements. The department will also be in contact with member organisations to facilitate this information being provided to all pharmaceutical companies to ensure a smooth transition to the new expedited listing arrangements.

Enquiries can be directed to the Pricing Section.

 

PBS Website Update – 1 March 2014

1 March 2014

The Schedule of Pharmaceutical Benefits was updated on 1 March 2014 and the Summary of Changes can be found on the New, Amended and Deleted Items page.

The following updates have also been made to the PBS Website:

Additional information - linagliptin with metformin (Trajentamet®) and saxagliptin with metformin (Kombiglyze®)

These products will have the same restriction as the recently-listed alogliptin with metformin (Nesina Met). They will be available for use as as an option in diabetes mellitus type 2 where initial treatment with metformin alone has not been sufficient to control a patient's diabetes.

 

PBS Website Update – 1 February 2014

1 February 2014

The Schedule of Pharmaceutical Benefits was updated on 1 February 2014 and the Summary of Changes can be found on the New, Amended and Deleted Items page.

The following updates have also been made to the PBS Website:

 

PBS mobile website

24 January 2014

A smart phone and tablet version of the PBS website is now available. Users of mobile devices now have the option to view either the standard or mobile versions of the PBS Website. The mobile version can be accessed directly via m.pbs.gov.au. Any feedback or questions regarding the mobile version can be emailed to the PBS Webmaster.

 

WA Bushfire Emergency - temporary PBS arrangements for fire-affected zones

17 January 2014

The Department of Health has introduced temporary arrangements to assist residents and pharmacists in fire-affected areas in WA to maintain medicine supplies.

The document: Advice for approved pharmacists supplying PBS medicines to patients in areas affected by bushfire in WA includes details on how pharmacists can manage additional supplies for residents whose medicine and prescriptions have been lost in the current bushfire emergency.

Please use the contact numbers in the information document for further information about bushfire-related medicine issues.

 

PBAC Guidelines website

16 January 2014

The Pharmaceutical Benefits Advisory Committee (PBAC) Guidelines v4.4 are now available at www.pbac.pbs.gov.au.

 

2014 PBS co-payment and safety net amounts

3 January 2014

In line with changes in the consumer price index, the PBS co-payment and safety net amounts have been revised.  Therefore, the following changes are effective on 1 January 2014:

  • the general patient co-payment will increase from $36.10 to $36.90;
  • the concessional co-payment will increase from $5.90 to $6.00;
  • the general safety net threshold will increase from $1,390.60 to $1,421.20 and
  • the concessional safety net will increase from $354.00 to $360.00.

 

PBS Website Update – 1 January 2014

1 January 2014

The Schedule of Pharmaceutical Benefits was updated on 1 January 2014 and the Summary of Changes can be found on the New, Amended and Deleted Items page.

The following updates have also been made to the PBS Website:

 

Summary of 1 April 2014 price reductions for the 2014 Main Cycle by drug/ manner of administration/ percentage reduction

16 December 2013

The summary of 1 April 2014 price reductions for the 2014 main cycle has now been published on the Price Disclosure (EAPD) page.

 

Price Disclosure (Simplified Price Disclosure)

11 December 2013

A stakeholder information session regarding the implementation of Simplified Price Disclosure was held at the Department of Health on 6 December 2013.

The presentation and additional information is now available.

 

PBS Website Update – 1 December 2013

1 December 2013

The Schedule of Pharmaceutical Benefits was updated on 1 December 2013 and the Summary of Changes can be found on the New, Amended and Deleted Items page.

The following updates have also been made to the PBS Website:

 

 

Contact Us

Department of Health
Ph: 1800 020 613
pbs@health.gov.au

Department of Human Services
(administers the PBS)
General enquiries 132 290
pbs@humanservices.gov.au

Dept of Veterans’ Affairs
RPBS enquiries
Ph: 1800 552 580

Poisons Information Centres
Ph 131 126 (24hrs)

Medicines Information Centre
NPS Medicines Line (for consumers only)
Ph: 1300 633 424

Therapeutic Goods Administration
Report adverse drug reactions
Ph: 1800 044 114

Consumer level recalls only
Ph: 1800 020 512

Telephone Interpreter Service
Ph: 131 450 (24hrs)

more contacts